Clinical trials
Expanded access Small Cell Lung Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Approved for marketing | 3 |
| No longer available | 3 |
| Available | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 2 |
| Amgen | 1 |
| Daiichi Sankyo | 1 |
| G1 Therapeutics, Inc. | 1 |
| Jazz Pharmaceuticals | 1 |
| Novartis Pharmaceuticals | 1 |
| Shandong Cancer Hospital and Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Small Cell Lung Carcinoma | 8 |
| Lung Neoplasms | 3 |
| Adenocarcinoma of Lung | 1 |
| Bites and Stings | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.